Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

347
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
347
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

418
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
418
Variability: Analysis01:11

Variability: Analysis

803
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
803
Data Validation01:15

Data Validation

3.7K
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
3.7K
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

486
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
486
Testing a Claim about Standard Deviation01:19

Testing a Claim about Standard Deviation

3.3K
A complete procedure to test a claim about population standard deviation or population variance is explained here.
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European bioanalysis forum recommendations for strengthening bioanalytical method transfer and validation through collaborative interactions.

Bioanalysis·2026
Same author

The insulin-like growth factor system and the progression of renal complications of type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Sensing of shear stress in vascular endothelial cells - from physiology to pathology.

Journal of cell science·2026
Same author

Challenges with Neural Anomalies in Hypoglossal Nerve Stimulator Implantation.

The Annals of otology, rhinology, and laryngology·2026
Same author

TabulaTime: Novel multimodal deep learning for Acute Coronary Syndrome prediction through environmental and clinical data integration.

Artificial intelligence in medicine·2026
Same author

Rheumatoid arthritis and osteoarthritis patients demonstrate comparable rates of major adverse cardiovascular events: a single-centre retrospective cohort study.

Rheumatology advances in practice·2026
Same journal

A simple, sensitive microsample LC-MS assay for quercetin and isorhamnetin in mouse and human plasma: application to EMIQ treatment in myotonic dystrophy type 1.

Bioanalysis·2026
Same journal

ADA assays for high-dose biologics: redefining drug tolerance through clinical insights.

Bioanalysis·2026
Same journal

Comparison of SERS spectral data sets of blood serum samples of hypopharyngeal cancer using silver and gold nanoparticles as substrates.

Bioanalysis·2026
Same journal

The Gyrolab platform for immunogenicity assessment and biotherapeutic and biomarker analysis: technical advances and bioanalytical applications.

Bioanalysis·2026
Same journal

Simultaneous quantification of D-penicillamine, D-penicillamine disulfide, and L-cysteine-D-penicillamine disulfide in human plasma: optimization of sample preparation and mass spectrometry procedures to support bioequivalence studies.

Bioanalysis·2026
Same journal

Development and preliminary clinical application of a time-resolved fluoroimmunoassay for anti-rituximab antibodies in membranous nephropathy.

Bioanalysis·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
04:50

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Published on: August 4, 2023

1.8K

European Bioanalysis Forum: recommendation for dealing with internal standard variability.

Stephen White1, Neil Adcock, Walid Elbast

  • 1Bioanalytical Science & Toxicokinetics, Drug Metabolism & Pharmacokinetics, GlaxoSmithKline R&D, Ware, UK.

Bioanalysis
|November 22, 2014
PubMed
Summary
This summary is machine-generated.

Monitoring internal standard (IS) response in analytical runs is crucial but lacks standardized methods. This study surveys European Bioanalysis Forum practices to recommend best approaches for managing IS response variability.

More Related Videos

Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS
08:24

Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS

Published on: January 23, 2026

213
Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
11:25

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis

Published on: July 11, 2014

35.3K

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
04:50

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Published on: August 4, 2023

1.8K
Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS
08:24

Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS

Published on: January 23, 2026

213
Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
11:25

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis

Published on: July 11, 2014

35.3K

Area of Science:

  • Analytical Chemistry
  • Bioanalysis
  • Pharmaceutical Analysis

Background:

  • Internal standard (IS) response monitoring is essential for analytical run integrity.
  • Current practices for assessing IS response variability lack standardization across laboratories.
  • The European Bioanalysis Forum (EBF) identified a need for best practice guidelines.

Purpose of the Study:

  • To survey current practices for monitoring internal standard response variability within EBF member companies.
  • To identify common challenges and approaches in managing IS response deviations.
  • To recommend a standardized, best-practice approach for assessing IS response in bioanalytical runs.

Main Methods:

  • A survey was distributed to European Bioanalysis Forum member companies to gather data on their internal standard monitoring practices.
  • Data analysis focused on identifying trends, common methodologies, and areas of divergence in IS response assessment.
  • A topic team was formed to review survey results and formulate recommendations.

Main Results:

  • Significant variation exists in the methodologies employed for monitoring internal standard response across different laboratories.
  • Commonly identified anomalies in IS response include drifts, shifts, and outliers.
  • A consensus emerged on the need for a more harmonized approach to IS response evaluation.

Conclusions:

  • Standardized monitoring and assessment of internal standard response are critical for reliable bioanalytical data.
  • The EBF recommends the adoption of a consistent, best-practice approach to manage IS response variability.
  • Implementing these recommendations will enhance data quality and inter-laboratory reproducibility in bioanalysis.